Conmed (CNMD) FCF Payout Ratio Growth (3y) (2015 - 2025)
Conmed (CNMD) FCF Payout Ratio Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -24.36% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -15.73% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 0.06% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 47.27% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -478.95% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 0.49% |
| 10 | Conmed | 1.55 Bn | 1.51 Bn | 197.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.36% |
| Sep 30, 2025 | -26.21% |
| Jun 30, 2025 | -16.42% |
| Mar 31, 2025 | 27.93% |
| Dec 31, 2024 | -6.26% |
| Sep 30, 2024 | -29.58% |
| Jun 30, 2024 | -5.85% |
| Mar 31, 2024 | -8.88% |
| Dec 31, 2023 | -29.22% |
| Sep 30, 2023 | -5.61% |
| Jun 30, 2023 | -55.78% |
| Mar 31, 2023 | -28.44% |
| Dec 31, 2022 | -60.79% |
| Sep 30, 2022 | 21.22% |
| Jun 30, 2022 | 10.00% |
| Mar 31, 2022 | -35.15% |
| Dec 31, 2021 | -12.20% |
| Sep 30, 2021 | 26.14% |
| Jun 30, 2021 | -17.22% |
| Mar 31, 2021 | 4.47% |